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Abstract
Background: Cardiac allograft vasculopathy (AV) is a pathological process of vascular remodeling leading to late graft 
loss following cardiac transplantation. While there is consensus that AV is alloimmune mediated, and evidence that the 
most important alloimmune target is medial smooth muscle cells (SMC), the role of the innate immune response in the 
initiation of this disease is still being elucidated. As ischemia reperfusion (IR) injury plays a pivotal role in the initiation of 
AV, we hypothesize that IR enhances the early innate response to cardiac allografts.
Methods: Aortic transplants were performed between fully disparate mouse strains (C3H/HeJ and C57BL/6), in the 
presence of therapeutic levels of Cyclosporine A, as a model for cardiac AV. Neutrophils were depleted from some 
recipients using anti-PMN serum. Grafts were harvested at 1,2,3,5d and 1,2wk post-transplant. Ultrastructural integrity 
was examined by transmission electron microscopy. SMC and neutrophils were quantified from histological sections in 
a blinded manner.
Results: Grafts exposed to cold ischemia, but not transplanted, showed no medial SMC loss and normal ultrastructural 
integrity. In comparison, allografts harvested 1d post-transplant exhibited > 90% loss of SMC (p < 0.0001). SMC partially 
recovered by 5d but a second loss of SMC was observed at 1wk. SMC loss at 1d and 1wk post-transplant correlated 
with neutrophil influx. SMC loss was significantly reduced in neutrophil depleted recipients (p < 0.01).
Conclusions: These novel data show that there is extensive damage to medial SMC at 1d post-transplant. By depleting 
neutrophils from recipients it was demonstrated that a portion of the SMC loss was mediated by neutrophils. These 
results provide evidence that IR activation of early innate events contributes to the etiology of AV.
Background
Cardiac transplantation remains the predominant treat-
ment for patients suffering from end stage heart failure
[1]. Although significant improvements in early survival
post-cardiac transplantation can be attributed to new
developments in immunosuppressive therapies, rates of
late rejection remain unchanged, yielding only 50% graft
survival at 10 years post-transplant [2]. One of the major
contributing factors for late cardiac graft failure is
allograft vasculopathy (AV) [3-5]. AV is a pathological
diagnosis that is characterized by vascular remodelling of
the graft coronary arteries which results in a neointimal
lesion that eventually impairs blood flow to the heart
[6,7]. Although the pathological changes of AV are well
documented, the etiology remains unclear.
There is general consensus that AV is an immune medi-
ated phenomenon [8-10]. Syngeneic transplants and
transplants into immune deficient mice (such as RAG 1-/-
mice) fail to develop AV [11-13]. In rodent models, CD8+
T cells ha ve been shown to be required for A V in the
presence of clinically relevant levels of immunosuppres-
sion and reconstitution of immunodeficient animals with
CD8+ T cells is sufficient to restore the development of
AV [14]. Recent evidence [15,16] indicates that allo-anti-
body may play a contributory role in AV, but is not essen-
tial for its development. While few debate the critical role
that T cells play in acute and chronic rejection of
allografts, only recently have studies begun to acknowl-
edge the extent to which the innate immune system regu-
lates the potency and nature of allograft rejection [17,18].
Although there is consensus that adaptive immunity
plays a pivotal role in AV, there remains controversy over
the target of alloimmune damage. Some [19-21] have pro-
posed that the damage to the endothelium initiates vas-
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culopathy, while we [22] and others [23] have
demonstrated medial damage to be more important.
Reidy and colleagues used a mechanical injury model of
vasculopathy and found that endothelial denudation was
insufficient to induce vasculopathy [23]. However, the
degree of vasculopathy correlated directly to the level of
medial smooth muscle cell (SMC) loss, causing Reidy et
al. to propose a relationship between SMC loss and
neointimal vasculopathy. Nejat et al. [24] provided evi-
dence that the extent of medial SMC loss correlated with
developing lesion formation in a fully mismatched
murine immunosuppressed transplant model. Human
autopsy material from late rejecting hearts is consistent
with the observations from rodents (unpublished).
Ischemia reperfusion (IR) injury is an inevitable and
important insult incurred during transplantation.
Extended cold ischemic times have been shown to exac-
erbate acute and chronic rejection making the clear link
between IR and immune mediated graft damage [12,25].
An important component of IR injury induced damage
occurs in the graft vasculature and may exacerbate innate
immune events which impact downstream adaptive
immune responses and the development of AV. Potent
inflammatory chemokines, such as tumour necrosis fac-
tor (TNF) and interleukin 1 (IL-1), are expressed in syn-
geneic and allogeneic grafts within hours of reperfusion
[26]. These, and other, chemokines promote the recruit-
ment of neutrophils (NФ) [12,26-29]. The functional
activity of these NФ and the implications of this early NФ
influx to later lesion development are unclear.
Methods
Animals
Male, 8-10 week old C3H/HeJ (C3H;H-2K) and C57BL/6J
(B6; H-2b) mice were used as donors to 8-10-week old
male B6 recipients. In one experiment, male 8-9 week old
C57BL/6J-Tg (ACTB-EGFP) 10sb/J (B6-GFP; H-2b) were
used as donors to C3H/HeJ recipients. All mice were pur-
chased from Jackson Laboratories (Bar Harbor, ME) and
maintained in the Carlton Animal Care Facility, Sir
Charles Tupper Medical Building, in a pathogen free
environment. Food and water were given ad libitum. All
animal experimentation was undertaken in compliance
with the guidelines of the Canadian Council on Animal
Care, under an approved animal protocol.
Aortic Interposition Graft
Abdominal aortic segments were transplanted as we have
previously described [30]. Briefly, a section of abdominal
aorta approximately 1 mm in length was harvested from
the donor mouse and flushed with saline solution and
maintained for 20 min in cold saline before transfer into
the recipient. The recipient infrarenal abdominal aorta
was isolated. After proximal and distal clamping, the
recipient aorta was transected and the donor aorta was
interposed with proximal and distal end-to-end anasto-
moses using interrupted 11-0 nylon suture. The clamps
were removed and blood flow was confirmed by direct
inspection.
Immunosuppression
Cyclosporine (CyA; Sandimmune iv™) was purchased
from QEII Pharmacy, Halifax, NS. Aortic allograft recipi-
ent mice were treated subcutaneously with CyA 50 mg/
kg/d in sterile saline for the duration of the experiment.
Neutrophil depletion
In some experiments neutropenia was induced in B6
recipients as described [31]. Briefly 500 uL rabbit-anti-
mouse PMN serum (1:10 in saline; Cedarlane; Burlington,
ON) was injected intraperitoneally (IP) for three consec-
utive days before surgery and every day afterwards. Com-
pared to a control experiment, this treatment resulted in
> 80% depletion of thioglycollate elicited peritoneal neu-
trophils assessed by Geimsa stained cytospins.
Histology
Aortas were harvested at 1d, 2d, 3d, 5d, 1wk and 2wk
post-transplantation. Aortic grafts were flushed with
heparinised saline and fixed in 10% formalin at 4°C for 16
h. Grafts were subsequently transferred to cold (4°C)
phosphate buffered saline (PBS) for 1-2 h and then trans-
ferred into 70% ethanol until processing. Samples were
embedded in paraffin and 5 μm cross sections were sec-
tioned with a microtome. Sections were stained with
Harris' Haematoxylin and 0.5% Eosin (H&E) for general
histology. SMC were enumerated based on nuclear mor-
phology, in a blinded fashion, after the staff were trained
by an anatomical pathologist.
GFP aortas were harvested at 5d and 2wk post-trans-
plant and fixed overnight in 4% paraformaldehyde in
phosphate buffer followed by overnight incubation in
30% sucrose. Aortas were embedded in 10% gelatin and
fixed overnight in 4% paraformalyde followed by 30%
sucrose. Gelatin blocks were frozen and sectioned at 10
μm using a Leica Cryostat (Wetzlar, Germany). Sections
were visualized by fluorescence microscopy on a Zeiss
Fluorescent microscope using a wavelength of 450-490
nm. All images were captured with a Zeiss AxioCam
camera (Carl Zeiss; Thornwood, NJ).
Transmission Electron Microscopy (TEM)
Aortic segments were fixed with 2.5% gluteraldehyde in
0.1 M sodium cacodylate buffer and post-fixed with 1%
osmium tetroxide. After washing, the segments were
incubated in 0.25-0.5% uranyl acetate, rinsed and dehy-
drated through acetone. Segments were embedded inKing et al. Journal of Cardiothoracic Surgery 2010, 5:52
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epon-araldite resin and sectioned using a Reichert Jung
Ultracut E ultramicrotome with a diamond knife. The
sections were stained with lead citrate and uranyl acetate
before examination on a JOEL 1230 transmission elec-
tron microscope at an accelerating voltage of 80 kV. Digi-
tal images were captured using a CCD digital camera.
Immunohistochemistry
Paraffin sections were deparaffinised in xylene, hydrated
through an ethanol series, washed in PBS and antigen
retrieval was performed. Endogenous peroxidase was
quenched with a 15 min incubation in 3% hydrogen per-
oxide. Non-specific blocking was performed with serum
specific to the secondary antibody used. The primary
antibodies used were rat anti-mouse neutrophil (1:1500;
Cedarlane; Burlington, ON), rat anti-mouse Ki-67
(1:1500; Dako; Mississagua, ON), and mouse anti-mouse
α-actin (1:1500; Sigma; Saint Louis, MO). Primary anti-
body was detected with the appropriate biotinylated sec-
ondary antibody. Sections were then incubated with a
peroxidase avidin/biotin complex kit (Vector Labs Inc;
Burlingame, CA). One drop of prepared 3,3'-diaminoben-
zidine (DAB; Dako; Mississauga, ON) in 1 ml of substrate
buffer was used as the chromogen. Sections were coun-
terstained with Mayer's Haematoxylin. All enumerations
were performed in a blinded fashion.
Statistics
Data are presented as mean ± SEM for each experimental
group. All statistics were performed using GraphPad
Prism® (GraphPad software Version 4; San Diego CA,
USA). Results were analyzed by unpaired t-tests using the
Welch's correction. Values of p < 0.05 were considered
significant.
Results
Medial SMC are lost immediately post-transplantation
To examine pathological events occurring immediately
post-transplantation, aortic allografts were transplanted
between fully disparate strain combinations (C3H to B6)
with calcineurin inhibitor (CNI) immunosuppression.
This model most closely mimics the clinical situation of
immunologically disparate grafts and CNI immunosup-
pression.
Figure 1 shows native aorta with substantial numbers of
SMC in the media by H&E and TEM (Fig 1a,b). To exam-
ine the effect of cold ischemia on SMC we examined
grafts after 20 min cold ischemia histologically and at the
ultrastructural level using TEM (Fig 1c,d). Native grafts
that were not exposed to cold ischemia and grafts
e x p o s e d  t o  2 0  m i n  c o l d  i s c h e m i a  ( b u t  e x a m i n e d  p r e -
transplantation) had normal ultrastructural integrity. We
observed well-preserved endothelium, healthy media
with numerous viable SMC and normal nuclear morphol-
ogy with peripheral chromatin and an intact nuclear
envelope. Mitochondria showed no evidence of damage
to the outer membrane and normal cristae morphology
(data not shown). In stark contrast, at 1d post-transplant,
endothelial cells and medial SMC were absent from the
intima and media respectively (Fig 1e,f). Nuclei observed
at this time point were lacking peripheral chromatin and
showed extensive nuclear blebbing. These observations
indica te that by 1d post -transplant, marked damage to
the medial SMC had occurred. Enumeration of SMC on
histological sections from native aorta, native aorta after
20 min cold ischemia (pre-transplant) and allogeneic
grafts harvested at 1d post-transplant (20 min cold isch-
emia) demonstrated that there is no SMC loss in the
grafts after 20 min cold ischemia and profound medial
SMC loss (> 90% vs native aorta) at 1d post-transplant
(Fig 2a). To eliminate the involvement of the adaptive
immune response, we enumerated SMC on histological
sections from syngeneic grafts (Fig 2b) which showed
similar profound SMC loss at 1d post-transplant.
Medial SMC repopulation of aortic grafts
Having established marked medial SMC loss immediately
(1d) following transplantation, we next examined
whether this damage was permanent or if SMC repopu-
lated the medial compartment. This is of significant
interest because we have previously shown [24] in this
model that medial SMC numbers are present at relatively
normal levels at 4wk post-transplant. To elucidate the
progression of SMC loss and repopulation, we enumer-
ated SMC in the grafts at 1d, 2d, 3d, 5d, 1wk and 2wk
post-transplant (Fig 3). SMC numbers began to recover
by 5d post-transplant until they unexpectedly declined
again at 1wk post-transplant (Fig 3). Another period of
SMC recovery was observed at 2wk post-transplant (Fig
3).
To examine the mechanisms by which SMC repopu-
lated the medial compartment serial sections from both
recovery periods (5d and 2wk) were stained with H&E,
Ki-67 and α-actin. At 5d post-transplant SMC had repop-
ulated the media (Fig 4a) and Ki-67 positive cells were
observed (Fig 4b). Regions of proliferation stained posi-
tive for α-actin (Fig 4c). Results were similar for the sec-
ond recovery at 2wk post-transplant (Fig 4d,e,f). These
findings demonstrate the entirely novel and surprising
finding of a biphasic loss and repopulation by prolifera-
tion of medial SMC immediately after transplant.
Recovering SMC are donor in origin
As SMC exhibited a biphasic recovery at 5d and 2wk
post-transplant, we next investigated whether the SMC
that repopulated the medial compartment were donor or
recipient in origin. The origin of recovering SMC is an
important consideration as it has been reported that lateKing et al. Journal of Cardiothoracic Surgery 2010, 5:52
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Figure 1 Dramatic SMC loss occurs by 1d post transplant. (a) and (b) native C3H aorta; (c) and (d) native C3H aorta after 20 min cold storage (pre-
transplant); (e) and (f) C3H allograft transplanted into B6 recipient harvested at 1d post-transplant. Arrow heads demarcate the media. Red arrows in-
dicate medial SMC. IEL = internal elastic lamina. SMC = smooth muscle cell. EC = endothelial cell. NФ = neutrophil.
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SMC loss is mediated by adaptive immunity [24]. If this is
the case, then the early recovered medial SMC must be of
donor origin to provide the necessary alloimmune target.
To examine the origin of recovering SMC, GFP-B6 aortas
were transplanted into C3H recipients in the presence of
50 mg/kg/d CyA and harvested at 5d and 2wk post-trans-
plant. Examination of native GFP aorta (Fig 5a), allografts
harvested at 5d (Fig 5b) or 2wk post-transplant (Fig 5c)
showed GFP-positive cells in the media. These results
confirm that the early recovering SMC are donor in ori-
gin.
Neutrophils infiltrate the media of allografts
NФ are commonly associated with ischemia reperfusion
injury and their ability to cause damage and death to
nearby cells is well-documented [27,32]. To investigate
their role in the early events following transplantation,
grafts were stained for the presence of NФ using immu-
nohistochemistry (Fig 6a). We observed NФ infiltration
in all vessel layers. NФ were enumerated in the media at
1d, 2d, 3d, 5d, 1wk and 2wk post-transplant (Fig 6b).
These results demonstrate that the first peak of NФ
influx into the media occurred at 1d post-transplant.
Figure 2 SMC numbers are preserved following cold storage but dramatically lost at 1d post transplant. (a) SMC counts per aortic cross sec-
tion (mean ± SEM) in native C3H aorta, native C3H aorta after 20 min cold ischemia (pre-transplant) and C3H allograft transplanted into a B6 recipient 
at 1d post-transplant; (b) SMC counts per aortic cross section (mean ± SEM) in native C3H aorta and B6 syngeneic graft at 1d post-transplant. n = 4-6 
per time point.
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After 1d post-transplant, there was a drop in NФ num-
bers followed by a second peak at 1wk. When the number
of NФ infiltrating the media over time was compared to
the level of SMC destruction, a clear inverse relationship
was observed (Fig 6b). This data suggests a causative link
between NФ infiltration and SMC loss in the media.
Neutrophil depletion ameliorates SMC loss
Our observation of significant medial NФ influx coupled
with the fact that they could be linked to medial SMC loss
led us to hypothesize that NФ depletion would prevent
SMC loss. B6 recipients were depleted of NФ for 3 con-
secutive days before surgery and daily until harvest at 1d
or 1wk post-transplant. In allograft controls harvested 1d
post-transplant the media was nearly devoid of SMC (Fig
7a). When recipients were depleted of NФ, there were
significantly more medial SMC compared to control (Fig
7b). Similarly, at 1wk post-transplant, at the time of the
second wave of SMC loss in controls (Fig 7c), NФ deple-
tion of recipients ameliorated this SMC loss significantly
(Fig 7d). SMC enumeration at 1d and 1wk post-transplant
(Fig 7e) with or without prior NФ depletion of recipients
confirms the results shown in the representative histolog-
ical images. These data provide strong evidence to sup-
port the hypothesis that NФ contribute significantly to
early medial SMC loss.
Discussion
It is generally accepted that IR injury is a significant event
in the initiation of solid organ transplant rejection
[9,12,25,33]. IR injury induces a robust inflammatory
response [27,34-36] which signals danger and leads to
effective adaptive immune responses [27,34,36]. Necrotic
injury due to ischemic damage also provides a pool of
alloantigen for dendritic cell uptake and presentation to
alloreactive T cells [37]. Prolonged ischemia results in
more robust acute cellular rejection events in experimen-
tal models and clinical studies. Early acute cellular rejec-
tion events have been shown in a variety of studies to be
an independent risk factor for the development of AV
[38-42]. Likewise, studies have demonstrated that
enhanced IR damage results in exacerbated late graft
rejection [12,25,43]. The mechanism(s) by which IR
aggravates AV may be upregulated innate immune
response to the IR-injured graft, direct effects of IR on
acute rejection, direct effects of IR-injury on late adaptive
immune events, or a combination thereof.
Figure 3 Medial SMC numbers follow a biphasic pattern of loss and recovery. SMC counts (mean ± SEM) per aortic cross section at 1d, 2d, 3d, 
5d, 1wk and 2wk post-transplant. n = 4-6 per time point.King et al. Journal of Cardiothoracic Surgery 2010, 5:52
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Our results demonstrate the novel finding that there
was a remarkable (> 90%) loss of medial SMC within 1d of
transplantation. This SMC loss did not occur only during
organ storage as evidenced by TEM studies which
revealed preserved medial SMC in aortic grafts prior to
transplantation but after exposure to cold ischemia.
Surprisingly, our study revealed that a second wave of
SMC loss occurred at the 1wk time point. The second
wave of medial SMC loss cannot be directly attributed to
IR injury because the grafts were not subjected to any
additional ischemic insult post-transplantation. Addi-
tionally, this second loss is unlikely to be mediated by T
cells, as we have demonstrated that in the presence of
CNI immunosuppression, T cells first infiltrate the graft
at 4-5wk post-transplant [44]. There was a similar signifi-
cant loss of SMC at 1d post-transplant in syngeneic trans-
plants which highlights the role of innate immunity in
this observed SMC loss. Coincident with SMC loss at 1d
and 1wk post-transplant there were two waves of NФ
influx into the media of allografts. NФ are the ubiquitous
Figure 4 The medial compartment is repopulated with proliferating SMC. Serial sections of C3H allograft transplanted into B6 recipient harvest-
ed at 5d post-transplant (a) H&E; (b) immunohistochemistry for Ki-67; (c) immunohistochemistry for α-actin. Serial sections of C3H allograft transplant-
ed into B6 recipient harvested at 2wk post-transplant (d) H&E; (e) immunohistochemistry for Ki-67; (f) immunohistochemistry for α-actin. Arrow heads 
demarcate the media. Arrows indicate medial SMC.
H&E Ki-67 -actin
c b a
7
5d
f d e
5d
2wk
Figure 5 The recovering SMC are donor in origin. (a) native B6-GFP aorta showing fluorescing medial SMC; (b) B6-GFP allograft transplanted into 
C3H recipient at 5d post-transplant showing scattered, fluorescing SMC within the media indicating their donor origin; (c) B6-GFP allograft transplant-
ed into C3H recipient at 2wk post-transplant showing well organized, fluorescing SMC within the media. Arrow heads demarcate the media. n = 3-4 
per time point.
Native GFP aorta 5d post-transplant 2wk post-transplant
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first responders to ischemic injury in either a syngeneic
or an allogeneic milieu. NФ are recruited to transplants
through chemokines secreted by the graft vasculature
[26,28,29]. NФ granules contain numerous proteases and
are capable of generating a variety of reactive oxygen spe-
cies, thus they have been implicated as mediators of dam-
age in models of myocardial infarction and
transplantation [27,45-49] and are potentially responsible
for some of the SMC damage early post transplantation.
When transplant recipients were depleted of NФ, medial
SMC were preserved, suggesting that NФ are responsible
for some of the profound SMC loss we witnessed early
after transplantation.
We have shown that SMC numbers recover with a
biphasic profile, similar to the two waves of SMC loss, at
5d and 2wk post-transplant. In theory SMC recovery
could be due to recipient precursor cells being recruited
to fill the medial compartment. However, given that
medial SMC numbers are at near normal levels by 4wk
post-transplant [24] after which time they fall precipi-
tously as a result of alloreactive CD8+ T cell mediated
killing [50], it seemed more plausible that the early recov-
ering SMC were donor in origin. By using GFP donor
grafts, we established that the recovering SMC were GFP
positive, indicating that they are donor in origin. Addi-
tionally, at the peak times of SMC recovery (5d and 2wk)
α-actin, Ki-67 positive SMC were present in the media,
further confirming that donor SMC which had been
spared in the media were repopulating by proliferation. It
is interesting to note that the SMC recovery in the medial
compartment is donor in origin. This is in stark contrast
to the neointimal lesion which we [51] and others [52]
have shown to be recipient in origin.
Previous studies have implicated ischemic damage to
endothelial cells as a potential initial insult in the devel-
opment of AV [19,20,33,53]. Many of the murine studies
have been viewed in the context of a paradigm where
endothelial events were thought to lead to medial SMC
de-differentiation and migration into the intimal com-
partment to induce the characteristic neointimal lesion of
AV [8,53-55]. Newer evidence has demonstrated two
important elements of this pathological process which
challenge the established paradigm of the primacy of
endothelial-based events in the development of AV. First,
in murine models, the neointimal lesion is predominantly
of recipient, not donor origin [51,52,56-59]. Second, in
murine models, damage to the media appears to be more
important that the endothelium in the induction of the
neointimal lesion in AV [22].
The role of early SMC loss in the eventual development
of AV is unclear. Our data, however, suggest that the
development of AV is considerably more complex than a
simple reaction to SMC loss. For instance, while there is a
direct link between late medial SMC loss (5-8wk) post-
transplant and neointimal lesion formation [24], there is
no neointimal lesion formation after early SMC loss (1d
Figure 6 Neutrophil infiltration is evident in the media of allografts immediately post transplant and inversely correlates with SMC loss. (a) 
C3H allograft transplanted into a B6 recipient harvested at 1d post-transplant showing NФ (indicated by arrows) within the media (demarcated by 
arrowheads); (b) mean medial SMC (red squares) and NФ (black circle) per aortic cross-section were enumerated between 1d and 2wk post-transplant. 
n = 4-6 per time point.
a
b
a
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or 1wk) post-transplant. Moreover, depletion of medial
SMC by adaptive immunity late post-transplant (5-8wk)
does not result in medial SMC repopulation. In contrast,
there is proliferation and repopulation of donor SMC in
the media which occurs early post-transplant (1d and
1wk).
These experiments were performed using CNI inhibi-
tion, the mainstay of immunosuppressive therapy post-
cardiac transplant. In the clinical situation patients
receive combination therapy. The impact of these addi-
tional therapies, particularly anti-proliferative therapies
on SMC recovery is unknown, but of significant clinical
relevance.
Conclusion
While there is no debate that the endothelium is injured
by IR and plays a role in the development of AV, emerging
evidence also suggests a significant role for the medial
Figure 7 Neutrophils mediate SMC loss. (a) C3H allograft transplanted into a B6 recipient harvested at 1d post-transplant with dramatic loss of SMC; 
(b) C3H allograft transplanted into NФ depleted B6 recipient at 1d post-transplant showing partial preservation of medial SMC; (c) C3H allograft trans-
planted into B6 recipient at 1wk post-transplant exhibits significant SMC loss; (d) C3H allograft transplanted into NФ depleted B6 recipient at 1wk post-
transplant with SMC present in the media; (e) mean ± SEM medial SMC counts for untreated control and NФ depleted recipients at 1d and 1wk post-
transplant. Arrow heads demarcate the media. Arrows indicate medial SMC. n = 3-6 per time point.
b a
1d
c d
1wk
eKing et al. Journal of Cardiothoracic Surgery 2010, 5:52
http://www.cardiothoracicsurgery.org/content/5/1/52
Page 10 of 11
S M C  i n  t h i s  pa t h o p h ys i o l ogy .  W e  h a v e  s h o wn ,  f o r  t h e
first time, early devastation of the medial compartment as
a result of IR and subsequent transplantation. We have
also shown that the innate immune system (NФ) is par-
tially responsible for the early medial SMC loss in our
allograft model. The interaction of the innate immune
system and subsequent adaptive immune systems in the
development of AV remains to be elucidated.
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